Annals of African Medicine

ORIGINAL ARTICLE
Year
: 2008  |  Volume : 7  |  Issue : 3  |  Page : 128--132

Prescription pattern of anti-hypertensive drugs in a tertiary health institution in Nigeria


E Etuk1, SA Isezuo2, A Chika1, J Akuche1, M Ali1,  
1 Department of Pharmacology, College of Health Sciences Usmanu DanFodiyo University, Sokoto, Nigeria
2 Department of Medicine, College of Health Sciences Usmanu DanFodiyo University, Sokoto, Nigeria

Correspondence Address:
E Etuk
Department of Pharmacology, College of Health Sciences, Usmanu Danfodiyo University, Sokoto, C/o P.O. Box 2298, Sokoto
Nigeria

Abstract

Objective: This study examined the pattern of physicians«SQ» prescription of antihypertensive drugs and its possible effects on blood pressure control as well as physicians«SQ» compliance with recommended guidelines. Methods: Records of 145 patients aged 17-91 (mean: 52.6±14.6) years, with male to female ratio of 1:1.2 were randomly selected. Information on antihypertensive prescriptions was recorded. Blood pressure control was defined as systolic and diastolic blood pressure less than 140 mm Hg and 90mmHg, respectively. Results: Of the 145 patients studied, 20% (29) were on monotherapy and 80% (116) on combination therapy. Of the patients on combination therapy, 61.2% (71), 33.6% (39) and 5.2% (6) were on 2, 3 and 4 drugs, respectively. Diuretic was the most frequently prescribed drug either as a single agent (44.8%) or as combination therapy (88.8%). Mean reductions in both systolic and diastolic blood pressures were more in patients on calcium channel blocker than those on diuretic monotherapy (t=2.5 and 3.6 for reductions in systolic and diastolic BP, respectively; P<.05 for both), and, in patients on combination therapy than those on monotherapy (t=3.64 and 3.27 for reductions in systolic and diastolic BP, respectively; P<.01 for both). Blood pressure control rate was 30.5%. Conclusion: Our results are consistent with the previously observed benefits of antihypertensive combination therapy, and demonstrate an apparent higher efficacy of calcium channel blocker monotherapy than diuretic monotherapy in blood pressure lowering in the study population. Major limitations of this work include its retrospective nature and the inability to determine the actual patients«SQ» adherence to therapy.



How to cite this article:
Etuk E, Isezuo S A, Chika A, Akuche J, Ali M. Prescription pattern of anti-hypertensive drugs in a tertiary health institution in Nigeria.Ann Afr Med 2008;7:128-132


How to cite this URL:
Etuk E, Isezuo S A, Chika A, Akuche J, Ali M. Prescription pattern of anti-hypertensive drugs in a tertiary health institution in Nigeria. Ann Afr Med [serial online] 2008 [cited 2019 Oct 22 ];7:128-132
Available from: http://www.annalsafrmed.org/text.asp?2008/7/3/128/55665


Full Text

 Introduction



Despite the availability of a wide range of anti-hypertensive drugs, hypertension and its complications are still important causes of adult morbidity and mortality in sub-Saharan Africa [1],[2] . More than 50% of treated hypertensive patients have a blood pressure level greater than 140/90 mm Hg (uncontrolled hypertension) [3],[4] . Several factors including, among others, poor adherence to therapeutic regimen, ignorance, and poverty [3],[4],[5] have been adduced for the high prevalence of uncontrolled hypertension. Recent reports have however focused on the role of health care provider to poor adherence to antihypertensive drugs [6],[7] . Consequently, compliance with standard guidelines aiding physicians in effective prescription of anti-hypertensive drugs have been emphasized [8] . This study is aimed at determining the physicians' prescription pattern of antihypertensive medications in a tertiary health institution in northwestern Nigeria. Physicians' compliance with the existing guidelines is described.

 Materials and Methods



This is a retrospective cross-sectional study done between 4th May and 2nd June 2006, in Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria. Records of 181 patients aged between 17-91years (mean: 52.6 ±14.6) with a male to female ratio of 1:1.2 were selected by simple random sampling technique using table of random numbers. Thirty six clinical records were excluded due to incomplete data. Of the remaining 145 patients studied, 14 who died on admission from complications of hypertension were also excluded from the calculation of treatment outcomes including blood pressure control and adherence rates.

Demographic and clinical information including age, gender, documented blood pressure at the time of first clinic attendance or admission, blood pressure at subsequent visits, and the anti-hypertensive medications were recorded. Prescription of a drug with fixed dose combination was considered as monotherapy. Blood pressure control was defined as the maintenance of blood pressures values less than 140/90 mm Hg during at least two successive appointments. [4],[8] Adherence to drug regimen was assessed in the in-patients using patients drug charts. Patients taking at least 80% of the prescribed tablets were considered adherent. In case of the out- patients, clinic adherence was determined using compliance with outpatient clinic appointments. [4] The last 4 scheduled clinic visits were assessed. Patients with 75% clinic attendance were regarded as clinic adherent, while patients with [4] Different grades of hypertension were defined using the 1999 WHO-ISH guidelines.[9]

Data analysis was done using the statistical program for the social sciences (SPSS) software. Continuous data are presented as mean ± standard deviation, while categorical data are presented as percentages. Differences between means of two groups were compared using student's t test, while that between proportions were compared using χ2 test. A p-value less than 0.05 was considered as significant.

 Results



The mean age of patients was 52.3 ± 14.6 years. Of the 145 patients studied, 53.8% and 46.2% were females and males, respectively. The most frequent grade of hypertension among the patients was severe hypertension (35.9%). Mild hypertension, moderate hypertension, and isolated systolic hypertension were observed in 29.0%, 29.0% and 5.5% of the patients respectively. The patterns of antihypertensive prescriptions are shown in [Table 1]. Of the 145 patients studied, 29 (20%) were on monotherapy, while 116 (80%) were on combination therapy. Of the 116 patients on combination therapy, 71(61.2%), 39 (33.6%) and 6 (5.2%) were on 2, 3 and 4 drugs, respectively. The most frequently prescribed antihypertensive is diuretic either singly (44.8%) or in combination with other anti-hypertensive drugs (88.8%). Two drug combinations appear to be the most frequent. It was prescribed in 26.8%, 38.0% and 29.6% of patients with mild, moderate and severe hypertension respectively. Monotherapy and 3 or 4 drug combinations were mainly prescribed for patients with mild (58.6%) and severe (68.9%) hypertension, respectively.

The baseline blood pressure tend to be higher as the number of drugs prescribed increases with the mean baseline blood pressures for patients on monotherapy and combination therapy being 154.8 ± 8.3/95.5 ± 9.1 and 175.6 ± 32.8/109.5 ± 18.7 mm Hg, respectively (PPP>.05 for both systolic and diastolic blood pressure reductions).

There was no significant difference in baseline blood pressures of patients on calcium channel blocker monotherapy and those on diuretic monotherapy [Table 3]. However, calcium channel blocker monotherapy significantly lowers blood pressures more than diuretic monotherapy (28.6 ± 16.8/12.9 ± 5.7 vs. 11.7 ± 7.1/4.4 ± 3.0 mm Hg; P[10] but higher than 56% reported by Isezuo and Njoku in Sokoto. [6] The high prescription rate of combination therapy may be due to the high prevalence of patients with severe and moderate hypertension, and the presence of co-morbid diseases, particularly diabetes mellitus. These findings are consistent with the recent trends advocating the use of combination therapy as a first line treatment.[10],[11],[12] Our observation that patients on combination therapy had significantly higher reduction in systolic and diastolic blood pressures than those on monotherapy further confirm the previously described benefits of antihypertensive combination therapy.

The choice of diuretic as the first line anti-hypertensive drug is consistent with other reports from Nigeria, [10],[13],[14] and in compliance with the current national [15] and JNC VII guidelines. [8] However, contrary to the traditional recommendations in most guidelines including the report of Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT),[16] calcium channel blocker was found to lower blood pressures more than diuretic when both were used as monotherapy. Though this finding is consistent with the reports of some other trials involving blacks, [17] it needs to be confirmed in a study involving a larger population.

We observed low frequency of prescription of ACEI or centrally acting agent such as alpha methyldopa as monotherapy. Furthermore, none of the patients in the study population was on beta-blocker monotherapy. These patterns of prescription agree with the traditional recommendations that neither ACEI nor beta-blocker monotherapy is effective in blacks. [15] The adverse effects of centrally acting antihypertensive agents have also been well described. [18] The frequency of prescription of ACEI was however high, in patients with co-morbid conditions. The benefits of ACEI in preventing cardiovascular events and target organs disease in patients with diabetes mellitus, heart failure, hypertensive renal insufficiency and diabetic nephropathy have been documented. [19]

The blood pressure (BP) control rate of 30.5% in the current report is similar to the value of 29% obtained in Ibadan [10] and the world wide epidemiological data showing fewer than 1 /3 of the hypertensive patients achieve blood pressure control. [8] Non-adherence [20] to treatment is the dominant factor contributing to inadequate BP control. In the current report we were unable to determine the actual drug adherence. It has been previously observed that blood pressure control rate is higher among clinic appointment compliant patients than the non-compliant ones. [4] Hence, low compliant rate with clinic appointment suggests that poor compliance to medication might have contributed to poor blood pressure control in the current report. We however recognized that clinic attendance does not necessarily imply adherence.

It has also been previously observed that in spite of the benefits of combination therapy, too many drug combinations may adversely influence patients' adherence and blood pressure control. [19] This may explain the apparent lack of significant further blood pressure reduction observed among patients on 3 or more drugs compared to those on 2 drug combinations in the current report. In conclusion, our results show that the choices of antihypertensive drugs reasonably comply with the national and international guidelines on the management of hypertension. The benefit of combination therapy over monotherapy as well as possible better efficacy of calcium channel blocker over diuretic in the study population was demonstrated. A major limitation of this work is its retrospective nature. Actual adherence could not be determined.

References

1Isezuo SA, Omotoso ABO, Gaye A, Corrah T, Araoye MA. One year survival among sub-Saharan Africans with hypertensive heart failure.Tropical Cardiology.2000; 26:57-60.
2Cappuccio FP, Micah FB, Emmett L, et al. Prevalence, detection, management and control of hypertension in Ashanti, West Africa.Hypertension. 2004; 43:1017-1022. Medline:15037552
3Salako BL, Ajose FA, Lawani E. Blood Pressure Control in a population where antihypertensives are given free.East Afr Med J. 2003; 80:529-531. Medline:15250626
4Isezuo AS, Njoku CH. Blood pressure control among hypertensives managed in a specialized health care setting in Nigeria.Afr J Med Med Sci. 2003; 32:65-70. Medline:15030069
5Isezuo SA, Opara TC. Hypertension awareness among Nigerian hypertensives in a Nigerian tertiary health institution.Sahel Medical Journal.2000; 3:93-97.
6Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States.N Engl J Med. 2001; 345:479-486. Medline:11519501
7Ren XS, Kazis LE, Lee A, Zhang H, Miller DR. Identifying patient and physician characteristics that affect compliance with antihypertensive medications.J Clin Pharm Ther. 2002; 27:47-56. Medline:11846861
8The seventh report of the joint national committee on prevention. Detection, evaluation, and treatment of high blood pressure (the JNC 7 report).JAMA. 2003; 289:2560-2571. Medline:12748199
9Guidelines Subcomittee. World Health Organization (WHO)/International Society of Hypertension (ISH) guidelines for the management of hypertension.J Hypertens. 1999; 17:151-185. Medline:10067786
10Yusuff KB, Balogun OB. Physicians' prescribing of antihypertensive combinations in a tertiary care setting in southwestern Nigeria.J Pharm Pharm Sci. 2005a; 8:235-242. Medline:16124935
11Neutel JM. The role of combination therapy in the management of hypertension. Oxford Journals.Nephrol Dial Transplant. 2006; 21:1469-1473. Medline:16714336
12Gavras I, Rosenthal T. Combination therapy as first-line treatment for hypertension.Curr Hypertens Rep. 2004; 6:267-272. Medline:15257860
13Adigun AQ, Ishola DA, Akintomide AO, Ajayi AAL. Shifting trends in pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real world evaluation of the efficacy, safety, rationality and pharmacoeconomics of old and new antihypertensive drugs.J Hum Hypertens. 2003; 17:277-285. Medline:12714973
14Yusuff KB, Balogun OB. Pattern of drug utilization among hypertensives in a Nigerian teaching hospital.Pharmacoepidemiol Drug Saf. 2005b; 14:69-74. Medline:15508134
15Guidelines Committee of the Nigerian Hypertension Society. Guidelines for the management of hypertension in Nigeria. Nigerian Hypertension Society.2005.
16The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: The Antihypertensive and Lipid-Lowering treatment to prevent heart attack trial (ALLHAT).JAMA. 2002; 288:2981-2997. Medline:12479763
17Centre for Reviews and Dissemination, University of York.Effectiveness of antihypertensive drugs in black people.Eff Health Care. 2004; 8:1-12.
18Douglas JG, Bakris GL, Epstein M, et al. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans. Working Group of the International Society on Hypertension in Blacks.Arch Intern Med. 2003; 163:525-541. Medline:12622600
19Guidelines Committee ESH-ESC. 2003 European Society on Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.J Hypertens. 2003; 21:1011-1053. Medline:12777938
20Yiannakopoulou ECh, Papadopulos JS, Cokkinos DV, Mountokalakis TD. Adherence to antihypertensive treatment: a critical factor for blood pressure control.Eur J Cardiovasc Prev Rehabil. 2005; 12:243-249. Medline:15942423